Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-10-016948
Filing Date
2010-12-03
Accepted
2010-12-03 19:15:47
Documents
1
Period of Report
2010-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6460
  Complete submission text file 0001179110-10-016948.txt   8279
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Brinkley David L (Reporting) CIK: 0001302445 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 101232759